Trial Profile
An open label comparative, multicentric study to assess the efficacy and safety of fixed dose combination capsules of Omeprazole and Cinitapride ER in comparison with Omeprazole capsules in patients suffering from non-ulcer dyspepsia (NUD) or gastroesophageal reflux disease (GERD).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Sep 2016
Price :
$35
*
At a glance
- Drugs Cinitapride/omeprazole (Primary) ; Omeprazole
- Indications Gastro-oesophageal reflux; Non-ulcer dyspepsia
- Focus Therapeutic Use
- 19 Mar 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India
- 08 Feb 2010 New trial record